Stay updated with breaking news from Eric Borin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery BusinessNew plant will produce drug delivery devices, employ 150 people in 2024 and up to 600 when full operations start in 2030MADRID, Spain, May 18, 2021 / B3C newswire / -- BD (...
BD Building $202M Manufacturing Facility In Spain By Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing. Sign up for our Construction newsletter You must correct or enter the following before you can sign up: Email (NOTE: Free email domains not supported) Primary area of interest Thank You! Law360 (M...
Investment includes new manufacturing facility in Europe. This content was submitted directly to this website by the supplier. Dec 14th, 2020 BD (Becton, Dickinson and Company), a global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations and add a new manufacturing facility in Europe. The new manufacturing facility in Europe is expected to be operational by the en...
New Clinical Trial Data Demonstrates BD Libertas Wearable Injector As A Drug Delivery System BD (Becton, Dickinson and Company), a leading global medical technology company, today announced publication of the results from a 52-subject human clinical trial with the BD Libertas Wearable Injector. The subcutaneous drug delivery system, currently in final phases of development, is designed as ready to use and to deliver drugs such as biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations. This research to evaluate the performance of the 5 mL BD Libertas device in human subj...